Survival rates drop precipitously when a tumor acquires the ability to metastasize to distant organs. The complexity of the metastatic process has, to date, precluded the approval therapeutics that specifically target metastasis. New options for treatment will become available as our mechanistic understanding of metastasis improves. This application responds to the Provocative Question #24: Given the difficulty of studying metastasis, can we develop new approaches, such as engineered tissue grafts, to investigate the biology of tumor spread? The vascular supply to a tumor is a major route for metastasis as motile cancer cells that have undergone epithelial mesenchymal transition (EMT) can intravasate into the vessels and be transported through the circulation to a distant site, such as the liver. The vascular supply to the tumor is extremely leaky and comprised of tortuous and unorganized vessels that have a profound impact on the tumor microenvironment including the concentration of growth factors (e.g., transforming growth factor ?, TGF?), interstitial pressure, and oxygen content. There are currently no in vitro models that recapitulate these prominent features of the tumor microenvironment, and thus the early events of metastasis. Employing microfluidic and tissue engineering technologies, our team of investigators has recently developed an in vitro high-throughput model of human microtissues (~ 1 mm3) that is perfused by living dynamic human microvessels. The model is primed to incorporate tumor spheroids and create a novel in vitro model of the tumor microenvironment that includes the essential feature of flow through human microvessels. The central objective of our application is to create a high-throughput platform of 3-D human tumor spheroids perfused by human microvessels that mimics EMT and intravasation. We hypothesize that intraluminal fluid shear stress impacts the efficiency of intravasation and tumor cell exit into the systemic circulation. This hypothesis can be uniquely addressed by our in vitro platform.
The specific aims focus on platform development, validation, and investigation: 1) develop and optimize a 3-D model of perfused human tumors by incorporating epithelial- derived tumor spheroids (human colorectal cancer) into a perfused network of 3-D human microtissues;2) validate an in vitro platform of tumor metastasis by stimulating (with TGF?, and/or hypoxia) and characterizing EMT and intravasation of human tumor spheroids within 3-D perfused microtissues;and 3) test the hypothesis that intraluminal fluid shear impacts endothelial permeability by affecting intercellula junctional integrity, and thus the efficiency of intravasation and exit into the """"""""systemic"""""""" circulation. Completing the specific aims will create and validate a new in vitro model of tumor metastasis that will significantly enhance the temporal and spatial resolution of the process. Finally, the model is flexible and, although our application will focus on intravasation, the model could also be used to examine other steps in metastasis such as extravasation and survival at a distant site.

Public Health Relevance

The central objective of our application is to create a high-throughput platform of 3-D human tumor spheroids perfused by human microvessels that mimics the early events of metastasis including epithelial mesenchymal transition (EMT) and intravasation. The flexible platform will provide new opportunities to study underlying mechanisms of metastasis, and thus new therapeutic options.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Greenspan, Emily J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Biomedical Engineering
Schools of Medicine
Saint Louis
United States
Zip Code
Shirure, Venktesh S; Bi, Ye; Curtis, Matthew B et al. (2018) Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip 18:3687-3702
Shirure, Venktesh S; Lezia, Andrew; Tao, Arnold et al. (2017) Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis. Angiogenesis 20:493-504
Sewell-Loftin, Mary Kathryn; Bayer, Samantha Van Hove; Crist, Elizabeth et al. (2017) Cancer-associated fibroblasts support vascular growth through mechanical force. Sci Rep 7:12574
Shirure, V S; George, S C (2017) Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms. Lab Chip 17:681-690
Sobrino, Agua; Phan, Duc T T; Datta, Rupsa et al. (2016) 3D microtumors in vitro supported by perfused vascular networks. Sci Rep 6:31589
Alonzo, Luis F; Moya, Monica L; Shirure, Venktesh S et al. (2015) Microfluidic device to control interstitial flow-mediated homotypic and heterotypic cellular communication. Lab Chip 15:3521-9
Ehsan, Seema M; George, Steven C (2015) Vessel network formation in response to intermittent hypoxia is frequency dependent. J Biosci Bioeng 120:347-50
Welch-Reardon, Katrina M; Ehsan, Seema M; Wang, Kehui et al. (2014) Angiogenic sprouting is regulated by endothelial cell expression of Slug. J Cell Sci 127:2017-28
Ehsan, Seema M; Welch-Reardon, Katrina M; Waterman, Marian L et al. (2014) A three-dimensional in vitro model of tumor cell intravasation. Integr Biol (Camb) 6:603-10